Fact CheckerSign in

NCT06095557Completed

MCG Discovery Study in Emergency Departments

Discovery Study of Using a Magnetocardiography (MCG) Device at Emergency Departments (EDs)

Source: ClinicalTrials.gov · Last updated 21 Oct 2025

Brief summary (registry, in English)

This prospective discovery study is designed to demonstrate the feasibility of using an unshielded, mobile MCG device in an Emergency Department (ED) setting. The main question it aims to answer is whether interpretable data can be reliably collected as part of an ED workflow.

Status (registry)
Completed
Study type
Interventional
Enrollment
124 (actual)
First submitted
12 Oct 2023
Start date
30 Oct 2023
Primary completion date
9 Jun 2025
Lead sponsor
SB Technology, Inc.
NCT number
NCT06095557

What you commit to

  • Study type: Interventional
  • Participants enrolled: 124
  • From 30 Oct 2023 to the primary completion date, 9 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Active thoracic metal implants

Other illness

  • Presents to ED with ST-Elevation Myocardial Infarction (STEMI)

Other

  • Presents to ED with Atrial Fibrillation
  • Clear non-ischemic cause for symptoms (i.e. trauma)

Who the study is looking for

  • Presents to ED with symptoms of Acute Coronary Syndrome (ACS)
  • Can provide written consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Icahn School of Medicine at Mount Sinai
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.